Statin users have an elevated risk of dysglycemia and new‐onset‐diabetes

Objective Statins are one of the most widely prescribed medications in the United States; however, there is a concern that they are associated with new‐onset‐diabetes (NOD) development. We sought to understand the risk of dysglycemia and NOD for a cohort of individuals that reflect real‐world physic...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes/metabolism research and reviews 2019-11, Vol.35 (8), p.e3189-n/a
Hauptverfasser:	Zigmont, Victoria A., Shoben, Abigail B., Lu, Bo, Kaye, Gail L., Clinton, Steven K., Harris, Randall E., Olivo‐Marston, Susan E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular diseases Diabetes Diabetes mellitus dysglycemia Glucose monitoring Hemoglobin inverse probability weighting Primary care statin use Statins survival analysis type 2 diabetes mellitus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!